Cytosorbents (CTSO) President Vincent Capponi Buys Stock

What Happened
Vincent Capponi, President and COO of Cytosorbents Corporation (CTSO), made two open‑market purchases on September 14, 2026, acquiring a total of 2,073 shares for $12,537. The trades were: 1,800 shares at $6.07 ($10,926) and 273 shares at $5.90 ($1,611). The filing reports these as purchase transactions (code P), reflecting open market buys.

Key Details

• Transaction dates and prices: 2026-09-14 — 1,800 shares @ $6.07 and 273 shares @ $5.90. Total cash outlay: $12,537. (Footnote F1: open market purchase.)
• Shares owned after transaction: filing indicates beneficial ownership of 25,736 common shares (see footnote F4).
• Related equity/awards disclosed: several RSU grants that may convert to shares upon vesting or a change in control — 505 (3/15/2018), 895 (2/24/2017), 2,700 (6/7/2016), 6,250 (4/8/2015) per F2, plus 4,455 RSUs from 8/8/2025 of which 2,228 remain unvested per F3.
• Corporate action: figures reflect a 1-for-20 reverse stock split effected by the company on September 8, 2026 (footnote F5).
• Filing timeliness: Form 4 was filed 2026-09-16 for transactions on 2026-09-14 — a timely disclosure (Form 4 due within two business days).

Context
These were straightforward open‑market purchases (P). Purchases by officers are factual disclosures of insider buying but do not by themselves explain motivation. The filing also discloses outstanding RSUs and current share ownership; note the reverse split adjusted reported share counts.